Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2026
Solid pancreatic lesions in young patients (<40 years): Should we be worried about? Lessons from 4 years of EUS guided FNB in a tertiary center.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Pretis Nicolò, Galli Maria Vittoria, Gasparini Irene, Mora Silvia Maria, Muretti Martina, Paredes Fernàndez Claudia, De Marchi Giulia, Amodio Antonio, Crucillà Salvatore, Caldart Federico, Mattiolo Paola, Luchini Claudio, Sina Sokol, Salvia Roberto, Conti Bellocchi Maria Cristina, Mantovani William, Martinelli Luigi, Crinò Stefano Francesco, Frulloni Luca
Аннотация
BACKGROUND: EUS-guided FNB is crucial in the management of solid pancreatic lesions (SPLs). Very little is known about SPLs and the risk of pancreatic cancer (PDAC) in young patients.
METHODS: All consecutive patients who have undergone EUS-guided FNB for non-metastatic SPLs between July 1st 2021 and June 30th 2025 at the Gastroenterology Unit of the University of Verona were evaluated retrospectively. Demographical, clinical, radiological and endoscopic data were extrapolated from a prospectively maintained database.
RESULTS: Among the 1250 included patients, 65 (5.2%) were younger than 40 years. The proportion of PDAC was 12.3% compared with 55.9% of patients older than 40 (p < 0.001). The most frequent SPLs were NET (44.6%) and solid pseudopapillary neoplasms (24.6%). Hypovascular pattern, dilation of the main pancreatic duct (MPD), and of the common bile duct (CBD) were associated with a significant increase of PDAC likelihood in both, general population and patients younger than 40 years. Finally, in 39 patients (60%) the SPLs required surgical resection and in 8 patients (12.3%) the SPLs were benign.
DISCUSSION: The proportion of SPLs in patients younger than 40 is remarkable in a tertiary center. Despite the probability of malignancy is lower in this setting, ruling out PDAC is crucial, particularly in case of hypovascular lesions with dilation of MPD and/or CBD.
METHODS: All consecutive patients who have undergone EUS-guided FNB for non-metastatic SPLs between July 1st 2021 and June 30th 2025 at the Gastroenterology Unit of the University of Verona were evaluated retrospectively. Demographical, clinical, radiological and endoscopic data were extrapolated from a prospectively maintained database.
RESULTS: Among the 1250 included patients, 65 (5.2%) were younger than 40 years. The proportion of PDAC was 12.3% compared with 55.9% of patients older than 40 (p < 0.001). The most frequent SPLs were NET (44.6%) and solid pseudopapillary neoplasms (24.6%). Hypovascular pattern, dilation of the main pancreatic duct (MPD), and of the common bile duct (CBD) were associated with a significant increase of PDAC likelihood in both, general population and patients younger than 40 years. Finally, in 39 patients (60%) the SPLs required surgical resection and in 8 patients (12.3%) the SPLs were benign.
DISCUSSION: The proportion of SPLs in patients younger than 40 is remarkable in a tertiary center. Despite the probability of malignancy is lower in this setting, ruling out PDAC is crucial, particularly in case of hypovascular lesions with dilation of MPD and/or CBD.